Measurement of proliferation activity in human melanoma xenografts by magnetic resonance imaging

Magnetic Resonance Imaging

Volumn 17, Issue 3, 1999, Pages 393-402

  Olsen, Gøril ^a   Lyng, Heidi ^a   Tufto, Ingunn ^a   Solberg, Kirsti ^a   Bjørnæs, Ingvil ^a   Rofstad, Einar K ^a  

^a INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

Human tumor xenograft; Proton T1 and T2; Quantitative MRI in vivo; S phase fraction; Tumor potential doubling time; Tumor volume doubling time

Indexed keywords

BROXURIDINE; DNA;

ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MELANOMA; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ANIMALIA;

EID: 0032949631     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0730-725X(98)00175-1     Document Type: Article

References (33)

1. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
2. Steel G.G. The growth kinetics of tumors. 1977;Oxford University Press, Oxford.
3. Ritter M.A. New approaches to cell kinetics in human tumors. Curr. Probl. Cancer. 17:1993;327-362.
4. Tubiana M. Tumor cell proliferation kinetics and tumor growth rate. Acta Oncol. 28:1989;113-121.
5. Wilson G.D. Assessment of human tumour proliferation using bromodeoxyuridine - current status. Acta Oncol. 30:1991;903-910.
6. Trott K.-R., Kummermehr J. What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother. Oncol. 3:1985;1-9.
7. Tubiana M., Arriagada R., Cosset J.M. Sequencing of drugs and radiation. The integrated alternating regimen. Cancer. 55:1985;2131-2139.
8. Girinsky T., Rey A., Roche B., Haie C., Gerbaulet A., Randrianarivello H., Chassagne D. Overall treatment time in advanced cervical carcinomas A critical parameter in treatment outcome . Int. J. Radiat. Oncol. Biol. Phys. 27:1993;1051-1056.
9. Girinsky T., Auperin A., Marsiglia H., Dhermain F., Randrianarivelo H., Kac J., Ducreux M., Elias D., Rougier P. Accelerated fractionation in esophageal cancers A multivariate analysis on 88 patients . Int. J. Radiat. Oncol. Biol. Phys. 38:1997;1013-1018.
10. Begg A.C., Hofland I., van Glabekke M., Bartelink H., Horiot J.C. Predictive value of potential doubling time for radiotherapy of head and neck tumor patients Results from the EORTC cooperative trial 22851 . Sem. Radiat. Oncol. 2:1992;22-25.
11. Zackrisson B., Gustafsson H., Stenling R., Flygare P., Wilson G.D. Predictive value of potential doubling time in head and neck cancer patients treated by conventional radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;677-683.
12. Lenner P., Roos G., Johansson H., Lindh J., Dige U. Non-Hodgkin lymphoma Multivariate analysis of prognostic factors including fraction of S-phase cells . Acta Oncol. 26:1987;179-183.
13. Tubiana M., Koscielny S. Cell kinetics, growth rate and the natural history of breast cancer. Eur. J. Cancer Clin. Oncol. 24:1988;9-14.
14. Stokke T., Smeland E.B., Kvaløy S., Holte H. Tumour proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkins lymphomas. Br. J. Cancer. 77:1998;1839-1841.
15. Rofstad E.K., Steinsland E., Kaalhus O., Chang Y.B., Høvik B., Lyng H. Magnetic resonance imaging of human melanoma xenografts in vivo Proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue . Int. J. Radiat. Biol. 65:1994;387-402.
16. 1H NMR relaxation times and water compartmentalization in experimental tumor models. Magn. Reson. Imaging. 4:1986;335-342.
17. Mitchell D.G., Burk D.L., Vinitski S., Rifkin M.D. The biophysical basis of tissue contrast in extracranial MR imaging. Am. J. Roentgenol. 149:1987;831-837.
18. Negendank W., Corbett T., Crowley M., Kellogg C. Evidence for a contribution of paramagnetic ions to water proton spin-lattice relaxation in normal and malignant mouse tissues. Magn. Reson. Med. 18:1991;280-293.
19. Rofstad E.K. Orthotopic human melanoma xenograft model systems for studies of tumour angiogenesis, pathophysiology, treatment sensitivity and metastatic pattern. Br. J. Cancer. 70:1994;804-812.
20. Gerlyng P., Stokke T., Huitfeldt H.S., Stenersen T., Danielsen H.E., Grotmol T., Seglen P.O. Analytical methods for the study of liver cell proliferation. Cytometry. 13:1992;404-415.
21. Begg A.C., McNally N.J., Shrieve D.C., Kärcher H. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample. Cytometry. 6:1985;620-626.
22. Rofstad E.K., Lindmo T., Brustad T. Effect of single dose irradiation on the proliferation kinetics in a human malignant melanoma in athymic nude mice. Acta Radiol. Oncol. 19:1980;261-269.
23. Remvikos Y., Vielh P., Padoy E., Benyahia B., Voillemot N., Magdelénat H. Breast cancer proliferation measured on cytological samples A study by flow cytometry of S-phase fractions and BrdU incorporation . Br. J. Cancer. 64:1991;501-507.
24. Belfi C.A., Medendorp S.V., Ngo F.Q.H. The response of the KHT sarcoma to radiotherapy as measured by water proton NMR relaxation times Relationships with tumor volume and water content . Int. J. Radiat. Oncol. Biol. Phys. 20:1991;497-507.
25. Bottomley P.A., Foster T.H., Argersinger R.E., Pfeifer L.M. A review of normal tissue hydrogen NMR relaxation times and relaxation mechanisms from 1 to 100 MHz dependence of tissue type, NMR frequency, temperature, species, excision, and age . Med. Phys. 11:1984;425-448.
26. Woodruff W.W., Djang W.T., McLendon R.E., Heinz E.R., Voorhees D.R. Intracerebral malignant melanoma high field MR imaging . Radiol. 165:1987;209-213.
27. Tripathi A., Bydden G.M., Hughes J.M., Pennock J.M., Goatcher A., Orr J.S., Steiner R.E., Greenspan R.H. Effects of oxygen tension on NMR spin-lattice relaxation rate of blood in vivo. Invest. Radiol. 19:1984;174-178.
28. Boucher Y., Jain R.K. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors Implications for vascular collapse . Cancer Res. 52:1992;5110-5114.
29. van Dijke C.F., Brasch R.C., Roberts T.P.L., Weidner N., Mathur A., Shames D.M., Mann J.S., Demsar F., Lang P., Schwickert H.C. Mammary carcinoma model Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density . Radiology. 198:1996;813-818.
30. Su M.-Y., Mühler A., Lao X., Nalcioglu O. Tumor characterization with dynamic contrast-enhanced MRI using MR contrast agents of various molecular weights. Magn. Reson. Med. 39:1998;259-269.
31. Takahashi Y., Kitadai Y., Bucana C.D., Cleary K.R., Ellis L.M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 55:1995;3964-3968.
32. Gullino P.M. Considerations of blood supply and fluid exchange in tumors. Gautherie M., Albert E. Biomedical Thermology. 1982;1-20 Alan R. Liss, New York.
33. Jakobsen I., Kaalhus O., Lyng H., Rofstad E.K. Detection of necrosis in human tumour xenografts by proton magnetic resonance imaging. Br. J. Cancer. 71:1995;456-461.